|
|
||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 267, Issue 5 901-G907, Copyright © 1994 by American Physiological Society
ARTICLES |
P. J. Mannon, S. J. Mervin and K. D. Sheriff-Carter
Division of Gastroenterology, Duke University Medical Center, Durham, North Carolina 27710.
Equilibrium binding studies showed that butyrate-treated HT-29 cells express a high-affinity 125I-labeled peptide YY (125I-PYY) binding site with a dissociation constant of 0.32 +/- 0.12 nM (mean +/- SE, n = 4). This site was Y1 preferring because neuropeptide Y (NPY) and the Y1-selective agonist [Leu31,Pro34]NPY were equipotent to PYY at displacing 125I-PYY; PYY-(13-36) and pancreatic polypeptide were > 1,000- and 10,000-fold less potent at displacing the radioligand. PYY and [Leu31,Pro34]NPY inhibited forskolin-stimulated adenosine 3',5'-cyclic monophosphate production 63% and 48%, respectively, with a half-maximal inhibitory concentration between 0.1 and 1.0 nM. PYY and [Leu31,Pro34]NPY had no effect on release of intracellular calcium alone or on the increase in intracellular calcium concentration caused by carbachol or neurotensin. Northern blot analysis of poly(A)+ RNA from HT-29 cells demonstrated a single transcript of 2.5 kb that hybridized to a human Y1-receptor cDNA probe. Sequence analysis of a reverse transcription-polymerase chain reaction product amplified with primers based on human Y1-receptor cDNA confirmed that these cells contained mRNA encoding the human Y1 receptor. These studies show that butyrate-treated HT-29 cells constitutively express the Y1-preferring NPY/PYY receptor and Y1 mRNA and provide a new model for studies of PYY-regulated epithelial cell function and tissue-specific expression of the human Y1-receptor gene.
This article has been cited by other articles:
![]() |
D. A. Keire, P. Mannon, M. Kobayashi, J. H. Walsh, T. E. Solomon, and J. R. Reeve Jr. Primary structures of PYY, [Pro34]PYY, and PYY-(3-36) confer different conformations and receptor selectivity Am J Physiol Gastrointest Liver Physiol, July 1, 2000; 279(1): G126 - G131. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Parker, M. S. Parker, T. Sweatman, and W. R. Crowley Characterization of G Protein and Phospholipase C-Coupled Agonist Binding to the Y1 Neuropeptide Y Receptor in Rat Brain: Sensitivity to G Protein Activators and Inhibitors and to Inhibitors of Phospholipase C J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 382 - 391. [Abstract] [Full Text] |
||||
![]() |
G. Hallden and G. W. Aponte Evidence for a Role of the Gut Hormone PYY in the Regulation of Intestinal Fatty Acid-binding Protein Transcripts in Differentiated Subpopulations of Intestinal Epithelial Cell Hybrids J. Biol. Chem., May 9, 1997; 272(19): 12591 - 12600. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |